Be Pharmaceuticals Ag recalls Fosaprepitant for Injection 150 mg per vial
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Sterility Assurance: Aseptic process simulation failure.
- Products
-
- Fosaprepitant for Injection 150 mg per vial
- Company
- Be Pharmaceuticals Ag
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 22,176 Vials
- About this recall
- Fosaprepitant for Injection 150 mg per vial, Sterile lyophilized powder for Intravenous use only after reconstitution and dilution, Single Dose Vial, Rx Only, Distributed by BE Pharmaceuticals Inc. 203 New Edition Court Cary, NC 27511, Made in India, NDC 71839-104-01.